GlobeNewswire by notified

BBS-Bioactive Bone Substitutes Oyj: The subscription period for the first warrant series starts on 21 November 2022 – the subscription price is EUR 0.92 per share

Share

BBS-Bioactive Bone Substitutes Oyj, Company release, 18 November 2022 at 2.30 p.m. EET

BBS-Bioactive Bone Substitutes Oyj (BBS) organized a rights issue from May 18 to June 3, 2022.

In connection with the share issue, a total of 670,962 warrants from two different series (TO1 and TO2) were also granted to the subscribers. Each warrant gives its owner the right to subscribe for one new share at a discounted price.

Information about the first series of warrants (TO1):

  • Subscription period: For the first warrant series (TO1), the subscription period starts on Monday 21 November 2022 and ends on Friday 2 December 2022.
  • Place of subscription: The subscription place in Finland is the account and asset managers and in Sweden Hagberg & Aneborn Fondkomission AB. The subscription order must be given in accordance with the instructions given by the holder’s account administrator or asset manager.
  • ISIN code: The ISIN code of the warrants (TO1) is FI4000522891.
  • Subscription price: The subscription price is EUR 0.92 or SEK 10.10 per share. The share subscription price (TO1) has been determined by the volume weighted average price of the company’s share on First North Finland between 7 November 2022 and 17 November 2022, with an applied discount of 25 per cent.
  • Trading: Warrants may be traded in Finland on Nasdaq First North Finland until 30 November 2022.

Terms and Conditions of Warrants (TO1) are available on the Share issue 2022 website: https://www.bbs-artebone.fi/wp/wp-content/uploads/2022/05/BBS-Warrant-Plan-1-2022-TO1-20220506-FINAL.pdf

For more information:

Ilkka Kangasniemi, CEO,
tel. +358 40 708 0307, e-mail: ilkka.kangasniemi@bbs-artebone.fi

Certified Advisor:
Nordic Certified Adviser AB, tel. +46 70 551 67 29, info@certifiedadviser.se

BBS in brief

BBS-Bioactive Bone Substitutes is a health technology company that started operations in 2003. We have developed a new product for the treatment of severe bone fractures and lumber problems. Our goal is to provide a new generation of medical products for the treatment of bone damage in orthopaedic surgery. In the pharmaceutical sector, development and research requires perseverance and courage to develop new things. We have evidence of this for over 20 years. Our activities are characterised by top expertise, innovation and employees who are enthusiastic and committed to their work. The ARTEBONE ® in the final stages of product development, and we are looking for a CE marking that enables commercialisation in the EU. We are a company in Oulu with a pharmaceutical factory permit in Reisjärvi.

BBS-Bioactive Bone Substitutes Oyj:n shares are listed in Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

More information: www.bbs-artebone.fi

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Mandalay Resources Corporation Announces Refinancing of Credit Facility2.12.2022 02:26:55 CET | Press release

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce that it has entered into a credit agreement with The Bank of Nova Scotia (“Scotiabank”) providing for a senior secured revolving credit facility in an aggregate amount of up to US$35 million (the “Revolving Credit Facility”). The initial drawdown under the Revolving Credit Facility will be used to repay the Company’s existing syndicated facility with HSBC Bank Canada and Macquarie Bank Limited (the “Existing Facility”) which had US$32.6 million outstanding before repayment. The residual proceeds from the Revolving Credit Facility will be used for general corporate and working capital purposes. The hedge arrangements entered into in connection with the Existing Facility will remain in place until their expiry in June 2023. The Revolving Credit Facility

Bond launches brand in Europe. Continuing to build new growth for clients across the globe2.12.2022 00:05:15 CET | Press release

Following the integration of recently acquired Buljan & Partners, Bond formally brings its purpose of championing growth to Europe and beyond TORONTO and MADRID, Spain, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Bond, a leading customer experience, loyalty, and growth firm, officially launched the Bond brand in Europe with a client event in Madrid followed by a road show of client presentations in Barcelona, Munich, Cologne and Hamburg. With an extensive footprint in Europe, Middle East and Africa (EMEA), the region will be led by Silvana Buljan, Executive Director of Bond, and founder of Buljan & Partners, acquired by Bond earlier in 2022. “Our business is built on a shared belief that human-centric brands are best positioned to develop tech-enabled connections, enduring relationships, and powerful bonds that drive unmatched growth,” said Buljan. “Since joining Bond in May, we have effectively combined the strength of both organizations to add greater value to the world-class brands we serve.

Alvotech Announces Changes to its Leadership Team1.12.2022 23:00:00 CET | Press release

Hafrun Fridriksdottir, previously Executive VP and Head of Global R&D at Teva, will become Chief Operating Officer Mark Levick has decided to step down as Chief Executive Officer and Robert Wessman, Executive Chairman and founder, will become CEO Changes to the leadership team are effective January 1, 2023 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to its leadership team. Mark Levick, Chief Executive Officer has decided to step down and Robert Wessman, Executive Chairman and founder will become CEO, leading the next phase of growth. Hafrun Fridriksdottir, previously Executive Vice President and Head of Global R&D at Teva, has been appointed Chief Operating Officer. Changes to the leadership team are effective January 1, 2023. “We continue positioning Alvotech for growth, as we transition from R&D and building an end-to-end biosimilars platform, to the next phas

Constellation Brands to Report Third Quarter Fiscal 2023 Financial Results; Host Conference Call January 5, 20231.12.2022 22:30:00 CET | Press release

VICTOR, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its third quarter ended November 30, 2022, on Thursday, January 5, 2023, before the open of the U.S. markets. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, Garth Hankinson, at 10:30 a.m. ET, January 5, 2023. The conference call can be accessed by dialing +1-877-407-9121 and entering conference identification number 13734749, beginning at 10:20 a.m. ET. A live, listen-only webcast of the conference call will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the call begins, financial information discussed on the conference call, and a reconciliation of reported GAAP financial measures with comparable or non

Leading Global Operator Selects Synchronoss to Deliver Personal Cloud Offering1.12.2022 22:16:14 CET | Press release

Leading Provider of Mobile, Telecommunications and ISP Services Rolling Out Personal Cloud Offering to Safeguard Files, Photos, Videos, and Other Digital Content BRIDGEWATER, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging and digital products and platforms, today announced a multi-year agreement with one of the largest global operators to deploy Synchronoss Personal Cloud to tens of millions of subscribers on its network. This agreement will contribute to Synchronoss’s financial results this quarter, as deployment preparations are underway, and transition into primarily a SaaS-based revenue model as subscribers adopt the service. As one of the world’s top providers of mobile devices and communications services, this international customer is partnering with Synchronoss to offer an array of value-added services, including the ability to backup and manage files, phot